Dysregulation of the endocannabinoid system - a key factor in the progression of multiple sclerosis?
{{output}}
The endocannabinoid system has been implicated in the pathophysiology of multiple sclerosis (MS), yet its role across different disease stages and under disease-modifying treatment remains incompletely understood. This study aimed to evaluate plasma levels of ... ...
